DIM (Diindolylmethane): What It Does to Estrogen, and What the Evidence Really Shows

A cruciferous vegetable compound that shifts how your body breaks down estradiol, backed by a handful of small human trials.

Track the foods that fit your goals. Track it free with Ration →

By the Ration Editorial Team · Reviewed against primary research · Updated July 13, 2026

Diindolylmethane, usually shortened to DIM, is a breakdown product of indole-3-carbinol.

Indole-3-carbinol forms when you chew or digest cruciferous vegetables. Stomach acid then converts it into DIM.

• Broccoli
• Cauliflower
• Cabbage
• Brussels sprouts
• Kale
• Bok choy

Because the amount of DIM you get from food is small and inconsistent, most research on its effects uses concentrated supplements rather than diet alone.

Estradiol, the main form of estrogen, gets broken down in the liver into different metabolites.

Some of these pathways produce metabolites considered more benign, while others are linked to more estrogenic or potentially harmful activity in tissue.

DIM appears to push this metabolism toward the pathway that favors 2-hydroxyestrone production over 16-alpha-hydroxyestrone, shifting the overall estrogen profile.^[2][3][5]

In cell studies, DIM also interacts with the aryl hydrocarbon receptor and estrogen receptor alpha, two proteins that control how estrogen-responsive genes get switched on.^[4][6]

This dual action on receptor signaling and metabolic pathways is the proposed mechanism behind DIM's effects on circulating estradiol.^[1]

Our database grades the effect of DIM on estradiol as a decrease, with an evidence grade of A based on 6 studies.

• ↓EstradiolAHuman trials

  Research may lower Estradiol · strong agreement · 6 studies

  View 5 studies on PubMed

  • 3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study (2011)
  • Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women (2023)
  • Resveratrol and 3,3'-Diindolylmethane Differentially Regulate Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha Activity through Multiple Transcriptomic Targets in MCF-7 Human Breast Cancer Cells (2023)
  • Exploring the impact of 3,3'-diindolylmethane on the urinary estrogen profile of premenopausal women (2024)
  • The impact of 3,3'-diindolylmethane on estradiol and estrogen metabolism in postmenopausal women using a transdermal estradiol patch (2025)

A 2025 study in postmenopausal women using transdermal estradiol patches found that DIM supplementation altered estradiol levels and estrogen metabolism even against a background of external hormone therapy.^[1]

In premenopausal women, DIM shifted the urinary estrogen metabolite profile toward the pathway associated with lower estrogenic activity.^[2]

A randomized controlled trial in premenopausal women reported that DIM supplements favored the benign estrogen metabolism pathway and were linked with reductions in body fat over the study period.^[3]

An earlier pilot RCT in patients with thyroid proliferative disease found DIM modulated estrogen metabolism in a similar direction, suggesting the effect is not limited to breast tissue.^[5]

Laboratory work in MCF-7 breast cancer cells has compared DIM with resveratrol, showing both compounds regulate estrogen receptor alpha and aryl hydrocarbon receptor activity, though through different transcriptomic targets.^[4][6]

Across this body of work, the direction of effect is consistent: DIM nudges estrogen metabolism toward less potent metabolites and tends to lower estradiol.^[1][2][3][5]

What is missing is large, long-duration trials that track hard outcomes like breast cancer incidence or bone health, so the current grade reflects consistent mechanistic and short-term hormonal data rather than proven disease prevention.

• People interested in shifting estrogen metabolism toward the pathway associated with lower estrogenic activity^[2][3]
• Women being evaluated for estrogen-related conditions, such as thyroid proliferative disease, in a research setting^[5]
• People already on estrogen therapy who are curious how DIM interacts with it^[1]
• Researchers studying plant compounds, alongside others like resveratrol, that affect estrogen receptor signaling^[4]

DIM is not typically used to treat any diagnosed condition, and the studies here are investigational rather than treatment trials.

Supplemental DIM is sold as capsules or tablets, often paired with black pepper extract or absorption enhancers because DIM on its own is poorly absorbed.

Doses used in the human trials cited here generally ranged from around 100 mg to over 200 mg per day, taken for periods of one to several months.^[1][2][3][5]

There is no established consensus dose, and commercial products vary considerably in strength and formulation.

In the trials available, DIM was generally tolerated over the study periods, which ranged from weeks to a few months.^[1][3][5]

Because DIM actively changes estrogen metabolism, anyone with a hormone-sensitive condition, or anyone using hormone therapy like a transdermal estradiol patch, should be aware that DIM can interact with that treatment.^[1]

Long-term safety data beyond a few months is limited, and most studies involve small groups of women rather than diverse, large populations.

Some users report darker urine, mild digestive upset, or headache, though these effects are not consistently quantified across the cited studies.

DIM has one of the more consistent human evidence bases among plant-derived supplements for a specific, measurable effect: shifting estrogen metabolism and lowering estradiol.^[1][2][3][5]

The mechanistic story, involving the aryl hydrocarbon receptor and estrogen receptor alpha, is well supported in cell studies.^[4][6]

What is still unproven is whether these hormonal shifts translate into meaningful long-term benefits like lower cancer risk, since the available trials are small and short.^[3][5]

Anyone considering DIM, especially alongside hormone therapy or a hormone-sensitive condition, is dealing with an active endocrine modulator rather than a simple vitamin, and that is worth taking seriously.^[1]